In a patient with mild‑to‑moderate euvolemic hyponatremia (e.g., SIADH), should initial management be free water restriction or oral sodium tablets, and what criteria dictate adding sodium tablets?

Management of Mild-to-Moderate Euvolemic Hyponatremia (SIADH)

For patients with mild-to-moderate euvolemic hyponatremia due to SIADH, fluid restriction to <1 L/day is the first-line treatment, with oral sodium tablets (100 mEq TID) added when fluid restriction alone fails to correct sodium levels or when patients cannot tolerate restriction. 1, 2

Initial Management Approach

First-Line: Fluid Restriction

For asymptomatic or mildly symptomatic SIADH with sodium 120-130 mEq/L:

• Restrict fluids to 1 L/day (or 1-1.5 L/day) 1, 2, 3
• Monitor sodium every 4 hours initially, then daily once stable 1
• Encourage high-protein diet to increase solute load 1
• This approach is effective in approximately 50% of SIADH patients 4

Critical caveat: Fluid restriction is often ineffective as monotherapy. Nearly half of SIADH patients do not respond adequately to fluid restriction alone 4. Real-world data shows fluid restriction monotherapy achieves only 0.8 mEq/L/day correction rate—significantly less effective than combination approaches 5.

When to Add Sodium Tablets

Add oral sodium chloride tablets (100 mEq three times daily) when 1:

• No response to fluid restriction after 24-48 hours (sodium not increasing or continuing to decline)
• Patient unable to adhere to strict fluid restriction
• Sodium remains <125 mEq/L despite 48 hours of fluid restriction
• Mild symptoms persist (nausea, headache, weakness) despite fluid restriction

The combination of fluid restriction plus sodium tablets produces significantly better correction rates (1.9 mEq/L/day) compared to either therapy alone 5.

Severity-Based Algorithm

Mild Hyponatremia (Na 126-135 mEq/L)

• Fluid restriction 1-1.5 L/day
• Monitor electrolytes
• No urgent intervention needed 6, 3

Moderate Hyponatremia (Na 120-125 mEq/L)

• Fluid restriction 1 L/day PLUS
• Sodium tablets 100 mEq TID if no improvement in 24-48 hours 1
• High-protein diet
• Monitor sodium every 4-6 hours initially

Severe or Symptomatic (Na <120 mEq/L or symptoms)

• This requires hypertonic 3% saline, NOT oral management
• Target correction: 6 mEq/L over 6 hours or until symptoms resolve
• Maximum 8 mEq/L in 24 hours to prevent osmotic demyelination 1

Important Clinical Pitfalls

Do NOT use isotonic (0.9%) saline in SIADH—it is ineffective and may paradoxically worsen hyponatremia because patients with SIADH excrete sodium while retaining free water 5. Isotonic saline monotherapy achieves only 1.3 mEq/L/day correction and has high failure rates 5.

Correction rate limits: Target 4-6 mEq/L per 24 hours in chronic hyponatremia, not exceeding 8 mEq/L per 24 hours to prevent osmotic demyelination syndrome 6, 3. Overcorrection occurred in 11.7% of cases in registry data 5.

Monitor for treatment failure: If sodium continues declining or fails to increase by at least 2-3 mEq/L after 48 hours of fluid restriction plus sodium tablets, escalate to second-line therapies (urea 30-60g/day or vaptans) 4, 7.

Monitoring Requirements

• Initial phase: Check sodium every 4-6 hours 1
• Once stable: Daily sodium monitoring
• Track: Daily weights, intake/output, urine sodium and osmolality
• Reassess diagnosis if no response—consider cerebral salt wasting, adrenal insufficiency, or hypothyroidism 2

The evidence strongly supports starting with fluid restriction but maintaining a low threshold to add sodium supplementation, as monotherapy failure rates are substantial and delayed correction is associated with worse outcomes 4, 5.